Abiopharma

🔍 Li David H (Executive)

Company: HEXCEL CORP /DE/ (HXL)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 2,697 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: M | equity_swap_involved: false | shares_owned_after: 4,239.00 | transaction_form_type: 4
• Sold 2,697 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-08 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a conditional right to receive one share of common stock of the issuer.
• F2: The RSUs vest on the earlier of (a) the first anniversary of the grant date and (b) the date immediately prior to the next annual meeting of stockholders following the grant date and will be converted into an equivalent number of shares of common stock of the issuer.